Delayed FH diagnosis can increase the risk of complications1

If left undetected and untreated, FH could lead to myocardial infarctions by age 40 in those with HeFH,2 and premature atherosclerotic cardiovascular disease in the first decade of life in those with HoFH.3,4

The importance of early FH diagnosis

Dr Don P. Wilson, MD, FNLA, and Dr Jason V. Terk, MD, discuss the underdiagnosis of FH despite its prevalence in the US, and how to support its diagnosis in practice.

Guidelines and recommendations​

Further reading for more information on pediatric lipid screening and FH diagnosis.

The National Heart, Lung and Blood Institute: Guidelines for cardiovascular health and risk reduction in children and adolescents

Early intervention and appropriate intervention can change the trajectory of FH.1

Visit resource

The American Heart Association: The agenda for familial hypercholesterolemia

Recommendations for heterozygous FH and homozygous FH diagnosis.5

Visit resource

The organizations listed are independent non-profit organizations.
Their inclusion here does not imply endorsement by Regeneron nor does it imply their endorsement of Regeneron or this resource center.

Discover more

Help us improve our content for you

​Take this 2-minute survey to let us know what you​
enjoyed about our website and what you would like to see in the future.​

Your valuable input will help us tailor our content to better suit your needs.

Take the survey


  1. Nordestgaard et al. Eur Heart J 2013;34:3478-90a.

  2. Luirink IK et al. N Engl J Med 2019;381:1547-1556.

  3. Cuchel M et al. J Am Heart Assoc 2023;12:e029175.

  4. Family Heart Foundation. (accessed February 2024).

  5. Gidding SS et al. Circulation 2015;132:2167–2192.